Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
Prevest Denpro Limited | NA | NA | NA | NA | 687.0 | 37.8 |
VENUS REMEDIES LTD. | 2,008.10 | 147.90 | 1,940.40 | 11.07 | 682 | 18.2 |
IND-SWIFT LABORATORIES LTD. | NA | NA | NA | NA | 641 | 7.75 |
Prevest Denpro Limited, with Security Code 543363, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Sep 2021 | Mar 2022 | Dec 2021 | Sep 2022 | Mar 2023 | Sep 2023 |
---|---|---|---|---|---|---|
Sales | 17.2 | 20.5 | 11.1 | 23.5 | 26.0 | 26.6 |
Expenses | 10.1 | 12.9 | 6.5 | 14.8 | 15.5 | 17.1 |
Operating Profit | 7.1 | 7.5 | 4.6 | 8.7 | 10.6 | 9.5 |
OPM % | 41.14% | 36.7% | 41.36% | 37.1% | 40.59% | 35.65% |
Other Income | 0.6 | 1.5 | 0.7 | 1.5 | 0.8 | 1.3 |
Interest | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.2 | 0.3 | 0.1 | 0.3 | 0.3 | 0.4 |
Profit before tax | 7.3 | 8.7 | 5.1 | 9.9 | 11.1 | 10.4 |
Tax % | -26.8% | -28.8% | -26.7% | -29.1% | -21.4% | -24.9% |
Net Profit | 5.4 | 6.2 | 3.8 | 7.0 | 8.7 | 7.8 |
EPS in Rs | 4.46 | 5.18 | 3.13 | 5.84 | 7.25 | 6.52 |
No Consolidated data available.
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 24% |
3 Years: | 26% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 40% |
3 Years: | 31% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 13% |
1 Year: | 17% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 13% |
1 Year: | 17% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
---|